Human chorionic gonadotropin. V. Synthesis of a triacontapeptide corresponding to the C-terminal sequence 116-145 of the β-subunit of human chorionic gonadotropin (hCG)

DOI: 10.1248/cpb.28.2714

Source and publish data:

Chemical and Pharmaceutical Bulletin p. 2714 - 2719 (1980)

Update date:2022-08-02

Topics:

Authors:

Okada Okada

Iguchi Iguchi

Yagyu Yagyu

et al. et al.

Read Full Text PDF DownLoad Join now for total 90,000,000 free articles

Article abstract of DOI:10.1248/cpb.28.2714

Full text of DOI:10.1248/cpb.28.2714

NII-Electronic Library Service

Products guided by the article

Product name:Hydrazinecarboxylic acid, 2-(2-amino-3-hydroxy-1-oxopropyl)-, 1,1-dimethylethyl ester, (S)-

Cas No:52615-95-9

R&D Labs maybe for 52615-95-9

Chengdu Pukang Biotechnology Co., Ltd

website:http://www.pu-kang.com

Contact:86-028-63976226

Address:No. 868 Xiwang Road,Xinjin county,Chengdu city, China
Kono Chem Co.,Ltd

website:http://www.konochem.com

Contact:86-29-86107037-8015

Address:No.11 Daqing Road,Lianhu District,Xi’an 710082,China
Beijing Zhongshuo Pharmaceutical T & D Co.,Ltd

Contact:0086-10-64430626

Address:ea No 16, HEPINGLI,DONGCHENG DISTRICT,BEIJING,P.R.CHINA.
Luojiang Chenming Biological Products Co

Contact:+86 15000297032

Address:GROUP NO.4, HE SHENG VILLAGE, PANLONG TOWN,
NanJing Rate Biochemicals CO., LTD

Contact:+86-25-84931986

Address:NO. 1 Hongjing Road,Jiangning Science Park,Nanjing,China

Relevant to this article

Remarkable catalytic effect of H⁺ in Michael-type additions of anilines to 3-butyn-2-one

Doi:10.1016/S0040-4020(01)00981-4
(2001)
Doi:10.1021/jo01062a617
(1961)
An enantioselective synthesis of the C₁-C₉ segment of antitumor macrolide peloruside A

Doi:10.1016/S0040-4039(03)00744-5
(2003)
Doi:10.1007/BF00502444
()
Synthesis of thiophene/phenylene co-oligomers. V [1]. Functionalization at molecular terminals toward optoelectronic device applications

Doi:10.1002/jhet.5570440417
(2007)
Oxazolo[4,5-b]pyridine-Based Piperazinamides as GSK-3β Inhibitors with Potential for Attenuating Inflammation and Suppression of Pro-Inflammatory Mediators

Doi:10.1002/ardp.201700022
(2017)

Article Doi